Live Breaking News & Updates on Theravance Inc

Stay updated with breaking news from Theravance inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Innoviva (NASDAQ:INVA) Downgraded to "Hold" at Zacks Investment Research

Innoviva (NASDAQ:INVA – Get Rating) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports. According to Zacks, “Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company’s portfolio of respiratory assets partnered […] ....

United States , South San Francisco , Thomson Reuter , Morgan Stanley , Rafferty Asset Management , Glaxo Group , Fieldpoint Private Securities , Zacks Investment Research , Financial Counselors Inc , Innoviva Company Profile Get Rating , Innoviva Inc , Theravance Inc , Royal Bank , Get Rating , Glaxo Group Limited , Director Innoviva , Private Securities , Company Profile , Nasdaq Inva ,